PPIRE02346

Target Protein Information
Protein_Name Dihydrofolate reductase
Protein_Sequence MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND
Organism_Source Homo sapiens
Functional_Classification Enzyme
Cellular_Localization Cytoplasm
Gene_Names DHFR
UniProt_ID P00374
Protein-Protein Interaction Networks
Peptide Basic Information
Peptide_Name Peptide 2
Peptide_Sequence FMYL
Peptide_Length 4
Peptide_SMILES CSCC[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
Chemical_Modification None
Cyclization_Method None
Linear/Cyclic Linear
N-terminal_Modification Free
C-terminal_Modification Free
Amino_Acid_Distribution
Peptide Physicochemical
Molecular_Weight 572.72
Aliphatic_Index 97.50000
Aromaticity 0.50000
Average_Rotatable_Bonds 4.00000
Charge_at_pH_7 -0.00287
Isoelectric_Point 6.09320
Number_of_Hydrogen_Bond_Acceptors 7
Number_of_Hydrogen_Bond_Donors 6
Topological_Polar_Surface_Area 170.85000
X_logP_energy 1.84290
Interaction Information
Affinity KD=0.7 uM
Affinity_Assay Isothermal titration calorimetry
PDB_ID None
Type Inhibitor
Structure
Reference Information
Document_Type Research Articles
Title Optimized peptide based inhibitors targeting the dihydrofolate reductase pathway in cancer.
Release_Year 2018
PMID 29453377
DOI 10.1038/s41598-018-21435-5